Rydex Health Care Fund Class A (RYHEX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
37.57
-0.25 (-0.66%)
Feb 14, 2025, 4:00 PM EST
2.18%
Fund Assets 26.49M
Expense Ratio 1.65%
Min. Investment $2,500
Turnover n/a
Dividend (ttm) n/a
Dividend Yield n/a
Dividend Growth n/a
Payout Frequency n/a
Ex-Dividend Date n/a
Previous Close 37.82
YTD Return 4.36%
1-Year Return 2.18%
5-Year Return 34.14%
52-Week Low n/a
52-Week High n/a
Beta (5Y) n/a
Holdings 122
Inception Date Sep 1, 2004

About RYHEX

The Fund's investment strategy focuses on Health/Biotech with 1.73% total expense ratio. The minimum amount to invest in Rydex Series Funds: Health Care Fund; A-Class Shares is $2,500 on a standard taxable account. Rydex Series Funds: Health Care Fund; A-Class Shares seeks capital appreciation by investing in companies that are involved in the health care industry.

Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol RYHEX
Share Class Class A
Index S&P 500 TR

Performance

RYHEX had a total return of 2.18% in the past year. Since the fund's inception, the average annual return has been 8.61%, including dividends.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol Provider Name Expense Ratio
FBTIX Fidelity Fidelity Advisor Biotechnology Fund - Class I 0.74%
FBIOX Fidelity Fidelity Select Biotechnology Portfolio 0.66%
FHCCX Fidelity Fidelity Advisor Health Care Fund - Class C 1.73%
FBTTX Fidelity Fidelity Advisor Biotechnology Fund - Class M 1.29%
FSHCX Fidelity Fidelity Select Health Care Services Portfolio 0.68%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
RYHIX Investor Class 1.40%
RYHAX Class H 1.65%
RYHCX Class C 2.40%

Top 10 Holdings

25.65% of assets
Name Symbol Weight
UnitedHealth Group Incorporated UNH 3.74%
Eli Lilly and Company LLY 3.70%
Johnson & Johnson JNJ 2.91%
AbbVie Inc. ABBV 2.71%
Merck & Co., Inc. MRK 2.30%
Intuitive Surgical, Inc. ISRG 2.26%
Abbott Laboratories ABT 2.23%
Thermo Fisher Scientific Inc. TMO 2.06%
Bristol-Myers Squibb Company BMY 1.87%
Boston Scientific Corporation BSX 1.86%
View More Holdings